Showing results (21-30 of 65) with videos related to
Sort By:
Pageof 7
Cancers|March 4, 2020
The Determination of Immunomodulation and Its Impact on Survival of Rectal Cancer Patients Depends on the Area Comprising a Tissue MicroarrayElisabeth S Gruber, Georg Oberhuber, Dietmar Pils, et al.The EMBO Journal|October 23, 2010
Crucial function of histone deacetylase 1 for differentiation of teratomas in mice and humansSabine Lagger, Dominique Meunier, Mario Mikula, et al.Oncotarget|February 27, 2016
Cooperation of ETV6/RUNX1 and BCL2 enhances immunoglobulin production and accelerates glomerulonephritis in transgenic miceEva Bauer, Michaela Schlederer, Ruth Scheicher, et al.Cell Reports|March 13, 2025
YAP1 is a key regulator of EWS::FLI1-dependent malignant transformation upon IGF-1-mediated reprogramming of bone mesenchymal stem cellsRahil Noorizadeh, Barbara Sax, Tahereh Javaheri, et al.Proceedings of the National Academy of Sciences of the United States of America|November 18, 2009
Epidermal loss of JunB leads to a SLE phenotype due to hyper IL-6 signalingPamina Pflegerl, Paul Vesely, Brigitte Hantusch, et al.Hepatology (Baltimore, Md.)|October 28, 2011
Growth-hormone-induced signal transducer and activator of transcription 5 signaling causes gigantism, inflammation, and premature death but protects mice from aggressive liver cancerKatrin Friedbichler, Madeleine Themanns, Kristina M Mueller, et al.Development (Cambridge, England)|January 23, 2014
A single allele of Hdac2 but not Hdac1 is sufficient for normal mouse brain development in the absence of its paralogAstrid Hagelkruys, Sabine Lagger, Julia Krahmer, et al.Blood|January 21, 2018
Microenvironment-induced CD44v6 promotes early disease progression in chronic lymphocytic leukemiaJulia C Gutjahr, Eva Szenes, Lisa Tschech, et al.Plos One|November 2, 2012
In vivo functional requirement of the mouse Ifitm1 gene for germ cell development, interferon mediated immune response and somitogenesisIngeborg Klymiuk, Lukas Kenner, Thure Adler, et al.Molecular Oncology|February 9, 2018
STAT1 is a sex-specific tumor suppressor in colitis-associated colorectal cancerIlija Crnčec, Madhura Modak, Claire Gordziel, et al.Pageof 7